Follow

The real costs of the new Alzheimer’s drug, most of which will fall to taxpayers tucsonsentinel.com/nationworld
The first drug purporting to slow the advance of Alzheimer’s disease is likely to cost the U.S. health care system billions annually even as it remains out of reach for many of the lower-income seniors most likely to suffer from dementia.

· · RSS feed · 0 · 5 · 3
Sign in to participate in the conversation
Tucson Sentinel Mastodon

Tucson Sentinel's independent nonprofit newsroom learns from & informs Southern Arizonans about the community challenges & unique culture of our Borderlands.